Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.21 - $0.39 $217 - $404
-1,037 Reduced 20.59%
4,000 $0
Q1 2023

May 15, 2023

SELL
$0.22 - $0.62 $927 - $2,612
-4,214 Reduced 45.55%
5,037 $1,000
Q4 2022

Feb 14, 2023

BUY
$0.38 - $1.91 $3,227 - $16,221
8,493 Added 1120.45%
9,251 $3,000
Q3 2022

Nov 14, 2022

BUY
$1.46 - $2.38 $594 - $968
407 Added 115.95%
758 $1,000
Q2 2022

Aug 15, 2022

SELL
$1.98 - $5.66 $407 - $1,165
-206 Reduced 36.98%
351 $1,000
Q1 2022

May 16, 2022

BUY
$4.52 - $12.9 $2,517 - $7,185
557 New
557 $3,000

Others Institutions Holding SNCE

About Science 37 Holdings, Inc.


  • Ticker SNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 116,348,000
  • Description
  • Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evid...
More about SNCE
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.